E-LIB Suche - Ergebnisse für: Klopp‐Schulze, Lena

1

Asia‐Inclusive Global Development of Enpatoran: Results of ..:

Klopp‐Schulze, Lena ; Gopalakrishnan, Sathej ; Yalkinoglu, Özkan...
Clinical Pharmacology & Therapeutics. 115 (2024) 6 - p. 1346-1357 , 2024

Link: https://doi.org/10.1002/..

2

Model‐based meta‐analysis using latent variable modeling to..:

Goteti, Kosalaram ; Garcia, Ramon ; Gillespie, William R....
CPT: Pharmacometrics & Systems Pharmacology. 13 (2023) 2 - p. 281-295 , 2023

Link: https://doi.org/10.1002/..

3

Enpatoran in COVID‐19 pneumonia: Safety and efficacy result..:

McKinnon, John E. ; Santiaguel, Joel ; Murta de Oliveira, Claudia...
Clinical and Translational Science. 16 (2023) 12 - p. 2640-2653 , 2023

Link: https://doi.org/10.1111/..

4

Applying Modeling and Simulations for Rational Dose Selecti..:

Klopp‐Schulze, Lena ; Shaw, Jamie V. ; Dong, Jennifer Q....
Clinical Pharmacology & Therapeutics. 112 (2022) 2 - p. 297-306 , 2022

Link: https://doi.org/10.1002/..

5

Phase 1 study in healthy participants of the safety, pharma..:

Port, Andreas ; Shaw, Jamie V. ; Klopp‐Schulze, Lena...
Pharmacology Research & Perspectives. 9 (2021) 5 - p. , 2021

Link: https://doi.org/10.1002/..

6

Obesity Alters Endoxifen Plasma Levels in Young Breast Canc..:

Mueller‐Schoell, Anna ; Klopp‐Schulze, Lena ; Schroth, Werner...
Clinical Pharmacology & Therapeutics. 108 (2020) 3 - p. 661-670 , 2020

Link: https://doi.org/10.1002/..

7

Perspectives on Model‐Informed Precision Dosing in the Digi..:

Kluwe, Franziska ; Michelet, Robin ; Mueller‐Schoell, Anna...
Clinical Pharmacology & Therapeutics. 109 (2020) 1 - p. 29-36 , 2020

Link: https://doi.org/10.1002/..

8

Selection of the Recommended Phase 2 Dose for Bintrafusp Al..:

Vugmeyster, Yulia ; Wilkins, Justin ; Koenig, Andre...
Clinical Pharmacology & Therapeutics. 108 (2020) 3 - p. 566-574 , 2020

Link: https://doi.org/10.1002/..

9

Computational Treatment Simulations to Assess the Need for ..:

Mueller-Schoell, Anna ; Michelet, Robin ; Klopp-Schulze, Lena...
Cancers. 13 (2021) 10 - p. 2432 , 2021

Link: https://doi.org/10.3390/..

10

Simulation-Based Assessment of the Impact of Non-Adherence ..:

Mueller-Schoell, Anna ; Klopp-Schulze, Lena ; Michelet, Robin...
Pharmaceuticals. 14 (2021) 2 - p. 115 , 2021

Link: https://doi.org/10.3390/..

11

518. Model-informed Dose Selection of Dual Toll-like Recept..:

Klopp-Schulze, Lena ; Shaw, Jamie ; Dong, Jennifer...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S360-S361 , 2021

Link: https://doi.org/10.1093/..

12

Integrated Data Analysis of Six Clinical Studies Points Tow..:

Klopp-Schulze, Lena ; Mueller-Schoell, Anna ; Neven, Patrick...
Frontiers in Pharmacology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

13

Erratum zu: CYP2D6-Genotypisierung vor Tamoxifen-Therapiest..:

Klopp-Schulze, Lena ; Kloft, Charlotte
best practice onkologie. 14 (2019) 10 - p. 454-454 , 2019

Link: https://doi.org/10.1007/..

14

Adherence to tamoxifen in breast cancer patients: What role..:

Schulz, Madlene ; Klopp-Schulze, Lena ; Keilhack, Stefanie...
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 152 (2018) 1 - p. 28-34 , 2018

Link: https://doi.org/10.1177/..

15

Exploiting Pharmacokinetic Models of Tamoxifen and Endoxife..:

Klopp-Schulze, Lena ; Joerger, Markus ; Wicha, Sebastian G....
Clinical Pharmacokinetics. 57 (2017) 2 - p. 229-242 , 2017

Link: https://doi.org/10.1007/..